NCCN Guidelines Updated to Include ctDNA-MRD Testing Recommendation for B-Cell Lymphoma | foresight-dx.com
Boulder, CO — January 10, 2025 — Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology, today announced the …